Euroasian Journal of Hepato-Gastroenterology

Register      Login

VOLUME 12 , ISSUE 1 ( January-June, 2022 ) > List of Articles

Original Article

A Tertiary Care Center's Experience with Clinicopathological Characteristics of Gallbladder Carcinoma in Our Population

Nishat Akbar, Taha Yaseen, Arz Muhammad, Muhammad Danish, Muhammad Adeel, Shoaib A Khan, Hina Ismail, Kiran Bajaj, Imdad Ali, Muhammad Q Panezai, Munir Tareen, Abbas A Tasneem, Syed M Laeeq, Farina Hanif, Nasir H Luck

Keywords : Demographics, Gallbladder, Gallbladder cancer

Citation Information : Akbar N, Yaseen T, Muhammad A, Danish M, Adeel M, Khan SA, Ismail H, Bajaj K, Ali I, Panezai MQ, Tareen M, Tasneem AA, Laeeq SM, Hanif F, Luck NH. A Tertiary Care Center's Experience with Clinicopathological Characteristics of Gallbladder Carcinoma in Our Population. Euroasian J Hepatogastroenterol 2022; 12 (1):35-39.

DOI: 10.5005/jp-journals-10018-1375

License: CC BY-NC 4.0

Published Online: 13-07-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Introduction: Gallbladder cancer (GBC) is the most common malignant biliary tract tumor with the shortest survival from the time of diagnosis. This poor prognosis is due to the destructive biologic behavior of GBC, lack of sensitive screening tests for early detection, and vague nature of first presentation. Here in this study, we will evaluate the baseline characteristics of the patients presenting with gallbladder carcinoma in our population. Materials and methods: This retrospective study was conducted in the Department of Gastroenterology at Sindh Institute of Urology and Transplantation (SIUT), Karachi. Patient data were compiled and composed from the in-patient health records, radiology, and operational records. Those patients with suspicion of GBC, but negative at histology, or patients having inconclusive radiologic findings, were excluded. Baseline characteristics were recorded. Results were presented as means ± SD for quantitative data or as numbers with percentages for qualitative data. Continuous variables were analyzed using the Student's t-test, while categorical variables were analyzed using the Chi-square test. A p-value of <0.05 was considered statistically significant. Results: A total of 162 patients were included in our study. Among them, 101 (62.3%) were females. Hypertension was the most common comorbid illness noted in 29 (17.9%) patients while 91 (56.2%) patients had no concurrent comorbidities. Most common risk factor for carcinoma of gallbladder was gallstones seen in 106 (65.1%) patients. The most common presenting complaint was combination of obstructive jaundice, weight loss with right hypochondrial pain seen in 66 (40.7%) patients. On CT abdomen, direct liver infiltration without lymphovascular invasion was noted in 77 (47.5%) patients followed by liver infiltration along with lymphovascular invasion in 26 (16%) patients and distant metastasis in 24 (14.8%) patients. On gallbladder (GB) mass biopsy, 58 (35.8%) patients had well-differentiated, 46 (28.4%) had moderately differentiated, while 33 (20.4%) had poorly differentiated adenocarcinoma. Of 162 patients, 103 (63.6%) patients underwent endoscopic retrograde cholangiopancreatography (ERCP). The most common finding on ERCP was proximal common bile duct (CBD) stricture with intrahepatic biliary system dilatation which was noted in 95 (58.6%) patients. Percutaneous transhepatic cholangiography (PTC) was performed only in 9 (5.6%) patients. Seventeen (10.5%) patients were managed by simple cholecystectomy, 39 (24.1%) patients underwent extended cholecystectomy, 14 (8.6%) patients underwent chemotherapy, while 102 (56.8%) patients were given palliative management. When followed for 1 year, 101 (62.3%) patients died within 6 months. Conclusion: The baseline characteristics, biopsy findings, modes of treatment, and rates of 1 year mortality were studied in patients with gallbladder carcinoma in our population. Advanced age, high white blood cell counts, and serum bilirubin at presentation with low lymphocyte count and presence of comorbid illnesses were the factors independently associated with increased mortality in patients with gallbladder carcinoma. However, further studies with large sample size and stratification with respect to age, gender, and different variables can be done in terms of mortality in patients with gallbladder carcinoma.


PDF Share
  1. Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 2004;4(9):695–706. DOI: 10.1038/nrc1429.
  2. Albores-Saavedra J, Henson DE, Klimstra DS. Tumors of the gallbladder, extrahepatic bile ducts and ampulla of vater. Atlas of tumor pathology, 3rd series, Fasc. 27. Washington, DC: Armed Forces Institute of Pathology; 1998. p. 37–111.
  3. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 2014;6:99–109. DOI: 10.2147/CLEP.S37357.
  4. Albores-Saavedra J, Menck HR, Scoazec JC, et al. Carcinoma of the gallbladder and extrahepatic bile ducts. In: Hamilton SR, Aaltonen LA, editors. World health organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 206–214.
  5. Randi G, Franceschi S, Vecchi CL. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006; 118(7):1591–1602. DOI: 10.1002/ijc.21683.
  6. Diehl AK. Epidemiology of gall bladder cancer: a synthesis of recent data. J Natl Cancer Inst 1980;65(6):1209–1214. PMID: 6933267.
  7. Prabhakaran PS, Aruna EP. Population based cancer registry, Bangalore, Kidwai Memorial Institute of Oncology, Bangalore. Individual registry data 1990–1996. p. 107–128.
  8. Schmidt MA, Marcano-Bonilla L, Roberts LR. Gallbladder cancer: epidemiology and genetic risk associations. Chin Clin Oncol 2019;8(4):31. DOI: 10.21037/cco.2019.08.13.
  9. Miller G, Jarnagin WR. Gallbladder carcinoma. Eur J Surg Oncol 2008;34(3):306–312. DOI: 10.1016/j.ejso.2007.07.206.
  10. Braghetto I, Bastias J, Csendes A, et al. Gallbladder carcinoma during laparoscopic cholecystectomy: is it associated with bad prognosis? Int Surg 1999;84(4):344–349. PMID: 10667815.
  11. Antonakis P, Alexakis N, Mylonaki D, et al. Incidental finding of gallbladder carcinoma detected during or after laparoscopic cholecystectomy. Eur J Surg Oncol 2003;29(4):358–360. DOI: 10.1053/ejso.2002.1402.
  12. The Southern Surgeons Club. A prospective analysis of 1518 laparoscopic cholecystectomies. N Engl J Med 1991;324(16): 1073–1078. DOI: 10.1056/NEJM199104183241601.
  13. Dutta U. Gallbladder cancer: can newer insights improve the outcome? J Gastroenterol Hepatol 2012;27(4):642–653. DOI: 10.1111/j.1440-1746.2011.07048.x.
  14. Kanthan R, Senger JL, Ahmed S, et al. Gallbladder cancer in the 21st century. J Oncol 2015;2015:967472. DOI: 10.1155/2015/967472.
  15. Do SI, Lee HW, Sohn JH, et al. Clinicopathologic characteristics of young patients with gallbladder cancer. Pathol Res Pract 2017;213(3):189–193. DOI: 10.1016/j.prp.2016.12.021.
  16. Gupta S, Gulwani HV, Kaur S. A comparative analysis of clinical characteristics and histomorphologic and immunohistochemical spectrum of gallbladder carcinoma in young adults (<45 years) and elderly adults (>60 years). Indian J Surg Oncol 2020;11(2):297–305. DOI: 10.1007/s13193-020-01044-3.
  17. Barreto SG, Haga H, Shukla PJ. Hormones and gallbladder cancer in women. Indian J Gastroenterol 2009;28(4):126–130. DOI: 10.1007/s12664-009-0046-8.
  18. Pandey M, Shukla VK. Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev 2003;12(4): 269–272. DOI: 10.1097/00008469-200308000-00005.
  19. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 2005;7(2):132–140. DOI: 10.1007/s11894-005-0051-8.
  20. Kang CM, Lee WJ, Choi GH, et al. Does “clinical” R0 have validity in the choice of simple cholecystectomy for gallbladder carcinoma? J Gastrointest Surg 2007;11(10):1309–1316. DOI: 10.1007/s11605-007-0225-9.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.